93 related articles for article (PubMed ID: 2977337)
1. The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis.
Thiemermann C; Ney P; Schrör K
Eur J Pharmacol; 1988 Oct; 155(1-2):57-67. PubMed ID: 2977337
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177).
Schrör K; Thiemermann C
Br J Pharmacol; 1986 Apr; 87(4):631-7. PubMed ID: 3011166
[TBL] [Abstract][Full Text] [Related]
3. Protection of the ischemic myocardium from reperfusion injury by prostaglandin E1 inhibition of ischemia-induced neutrophil activation.
Schrör K; Thiemermann C; Ney P
Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):268-74. PubMed ID: 2848205
[TBL] [Abstract][Full Text] [Related]
4. Daltroban, a thromboxane receptor antagonist, protects the myocardium against reperfusion injury following myocardial ischemia without protecting the coronary endothelium.
Viehman GE; Ma XL; Lefer AM
Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):651-6. PubMed ID: 1966110
[TBL] [Abstract][Full Text] [Related]
5. Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
Smith EF; Griswold DE; Egan JW; Hillegass LM; DiMartino MJ
J Cardiovasc Pharmacol; 1989 May; 13(5):715-22. PubMed ID: 2472519
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
Bhat AM; Sacks H; Osborne JA; Lefer AM
Am Heart J; 1989 Apr; 117(4):799-803. PubMed ID: 2929397
[TBL] [Abstract][Full Text] [Related]
7. Effect of enalapril or the thromboxane receptor antagonist, daltroban, in rats with subtotal renal ablation.
Brooks DP; Contino LC; Trizna W; Edwards RM; Ohlstein EH; Solleveld HA
J Pharmacol Exp Ther; 1990 Apr; 253(1):119-23. PubMed ID: 2139468
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits.
Osborne JA; Lefer AM
Am J Physiol; 1988 Aug; 255(2 Pt 2):H318-24. PubMed ID: 2970233
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of a thromboxane receptor antagonist (BM 13.505) on platelet hyperreactivity and thromboxane formation in cholesterol-fed rabbits.
Löbel P; Schrör E; Schrör K
Biomed Biochim Acta; 1988; 47(10-11):S86-9. PubMed ID: 3073772
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC
Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979
[TBL] [Abstract][Full Text] [Related]
11. BM 13.505, a selective thromboxane receptor antagonist, reduces myocardial infarct size following coronary artery reperfusion.
Smith EF; Earl CQ; Egan JW
Prostaglandins Leukot Essent Fatty Acids; 1989 Oct; 38(1):15-23. PubMed ID: 2532749
[TBL] [Abstract][Full Text] [Related]
12. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats.
Brezinski ME; Yanagisawa A; Darius H; Lefer AM
Am Heart J; 1985 Dec; 110(6):1161-7. PubMed ID: 3000159
[TBL] [Abstract][Full Text] [Related]
13. Selective thromboxane A2 receptor blockade in experimental exercise-induced myocardial ischaemia in dogs.
Thaulow E; Guth BD; Schulz R; Ross J
Acta Physiol Scand; 1989 Jul; 136(3):321-30. PubMed ID: 2526449
[TBL] [Abstract][Full Text] [Related]
14. Investigations of the antiatherosclerotic effect of the thromboxane A2 receptor antagonist Daltroban.
Pill J; Wolf O; Schmelz A; Stegmeier K; Metz J
Z Kardiol; 1990; 79 Suppl 3():155-60. PubMed ID: 2151550
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective actions of pentoxifylline in an animal model of acute myocardial ischaemia.
Gallenkämper W; Rücker W; Schrör K
Br J Pharmacol; 1984 Apr; 81(4):575-81. PubMed ID: 6547067
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of acute myocardial ischaemia with teopranitol--a novel organic nitrate.
Thiemermann C; Smith EF; Schrör K
Eur Heart J; 1986 May; 7(5):418-24. PubMed ID: 3732290
[TBL] [Abstract][Full Text] [Related]
17. Daltroban blocks thromboxane responses in the pulmonary vascular bed of the cat.
Hood JS; Nossaman BD; Ibrahim IN; McMahon TJ; Babycos CR; Kadowitz PJ
J Appl Physiol (1985); 1992 Jun; 72(6):2305-10. PubMed ID: 1385804
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of antagonism of thromboxane receptors in vascular smooth muscle.
Yanagisawa A; Smith JA; Brezinski ME; Lefer AM
Eur J Pharmacol; 1987 Jan; 133(1):89-96. PubMed ID: 3030773
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
[TBL] [Abstract][Full Text] [Related]
20. Protection of the ischaemic myocardium from reperfusion injury by defibrotide and its possible mechanism of action.
Thiemermann C; Ney P; Schrör K
Biomed Biochim Acta; 1988; 47(10-11):S19-22. PubMed ID: 3248105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
